Global Rubella Diagnostic Testing Market Report 2024

Rubella Diagnostic Testing Global Market Report 2024 – By Diagnostic Technique (Latex Agglutination, Liver Function Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques ), By Age Group (Neonates, Teenagers, Adults), By End User (Hospitals And Clinics, Cancer Diagnostic Centers, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

Rubella Diagnostic Testing Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : November 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Global Rubella Diagnostic Testing Market Infographic

Proud Members Of

checkslacipN checkaoirsN checkscipN

Rubella Diagnostic Testing Market Definition

Rubella diagnostic testing refers to the methods used to detect the presence of rubella virus or antibodies in a patient's blood to confirm if they have been infected with rubella or have immunity against it. These tests help healthcare providers diagnose rubella accurately and manage its implications, especially in vulnerable populations.

The main types of diagnostic techniques in rubella diagnostic testing are latex aggregation, liver function tests, enzyme immunoassay (EIA), radioimmunoassay (Ria), fluorescent immunoassay (FIA), and others. Latex agglutination is a diagnostic method where tiny latex beads coated with rubella-specific antigens or antibodies are mixed with a patient’s sample. This technique is applicable across various age groups, including neonates, teenagers, and adults, and serves a range of end users such as hospitals and clinics, cancer diagnostic centers, ambulatory surgical centers, and others.

Rubella Diagnostic Testing Market Segmentation

The rubella diagnostic testing market covered in this report is segmented –

1) By Diagnostic Technique: Latex Agglutination, Liver Function Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques

2) By Age Group: Neonates, Teenagers, Adults

3) By End User: Hospitals And Clinics, Cancer Diagnostic Centers, Ambulatory Surgical Centers, Other End Users

Global Rubella Diagnostic Testing Market Size 2023 to 2028: Graph

Rubella Diagnostic Testing Market Size 2024 And Growth Rate

The rubella diagnostic testing market size has grown strongly in recent years. It will grow from $1.22 billion in 2023 to $1.30 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to a rise in vaccination programs, a rising incidence of immunization-preventable outbreaks, government initiatives to combat the rubella virus, and the expansion of diagnostic testing in non-traditional settings.

Rubella Diagnostic Testing Market Growth Forecast

The rubella diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing healthcare expenditure, growing focus on preventive healthcare, rising awareness of vaccine-preventable diseases, growing public health campaigns, and expansion of telemedicine and remote diagnostics. Major trends in the forecast period include advancements in diagnostic technologies, technological integration in healthcare systems, development of point-of-care testing solutions, development of new diagnostic methods, and advancements in molecular diagnostics.

Rubella Diagnostic Testing Market Driver: The Rising Cases Of Viral Infections Propelling The Growth Of The Rubella Diagnostic Testing Market

The rising cases of viral infections are expected to propel the growth of the rubella diagnostic testing market going forward. Viral infections are illnesses caused by viruses, tiny infectious agents that can only replicate inside the living cells of an organism. The rising cases of viral infections are due to increased global travel, which facilitates the spread of viruses across borders, and climate change, which alters vector habitats and extends the range of disease-carrying organisms. Rubella diagnostic testing helps identify and manage rubella infections early, preventing complications, particularly in pregnant women, and aiding in outbreak control to reduce virus spread. For instance, in December 2023, according to the National Health Service, a UK-based government department, the number of daily hospital admissions for flu averaged 234, marking a 53% increase from the previous week, while hospital cases of norovirus rose by 15% to an average of 406 daily, reflecting a 28% increase from the same week last year. Therefore, the rising cases of viral infections are driving the growth of the rubella diagnostic testing market.

Global Rubella Diagnostic Testing Market Major Players

Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH

Global Rubella Diagnostic Testing Market Trend: Innovative Solutions In Rubella Diagnostics And Vaccination

Major companies operating in the rubella diagnostic testing market are focusing on developing innovative solutions, such as a rubella virus vaccine, to enhance diagnostic accuracy and improve preventive measures. The rubella virus vaccine is a vaccine that provides immunity against rubella, often administered as part of the MMR or MMRV combination vaccines to prevent the disease and associated complications. For instance, in March 2023, Merck & Co., Inc., a US-based pharmaceutical company, received FDA approval for the intramuscular (IM) administration of Merck’s M-M-R II vaccine, which is crucial in protecting against rubella, along with measles and mumps. This approval allows healthcare providers to administer the rubella vaccine using the IM route, making it consistent with other routinely recommended pediatric vaccines. Rubella vaccination is essential for preventing outbreaks and protecting against the severe complications the virus can cause, particularly in pregnant women.

Rubella Diagnostic Testing Market Merger And Acquisition: Leinco Technologies Acquires QED Biosciences To Expand Antibody Portfolio And Strengthen Life Sciences Capabilities

In September 2024, Leinco Technologies Inc., a US-based developer of high-purity antibodies, acquired QED Biosciences for an undisclosed amount. Through this acquisition, Leinco Technologies aims to expand its antibody product portfolio and development services, enhancing its life sciences and in vitro diagnostics capabilities while supporting its growth strategy and commitment to innovation and quality for global researchers. QED Biosciences is a US-based developer of novel monoclonal and polyclonal antibody products and offers rubella diagnostic testing services.

Regional Insights For The Global Rubella Diagnostic Testing Market

North America was the largest region in the rubella diagnostic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the rubella diagnostic testing market report areAustralia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rubella diagnostic testing market consists of revenues earned by entities by providing services such as serological testing services, serologic tests, molecular diagnostic services, and rapid diagnostic testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The rubella diagnostic testing market also includes sales of serological assays, IgM antibodies, rapid diagnostic tests (RDTs), and polymerase chain reaction (PCR) tests. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The rubella diagnostic testing market research report is one of a series of new reports from The Business Research Company that provides rubella diagnostic testing market statistics, including rubella diagnostic testing industry global market size, regional shares, competitors with a rubella diagnostic testing market share, detailed rubella diagnostic testing market segments, market trends and opportunities, and any further data you may need to thrive in the rubella diagnostic testing industry. This rubella diagnostic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Rubella Diagnostic Testing Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2024 $1.30 billion
Revenue Forecast In 2033 $1.68 billion
Growth Rate CAGR of 6.6% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Diagnostic Technique: Latex Agglutination; Liver Function Tests; Enzyme Immunoassay (EIA); Radioimmunoassay (Ria); Fluorescent Immunoassay (FIA); Other Diagnostic Techniques
2) By Age Group: Neonates; Teenagers; Adults
3) By End User: Hospitals And Clinics; Cancer Diagnostic Centers; Ambulatory Surgical Centers; Other End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd, bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Rubella Diagnostic Testing Market Characteristics

    3. Rubella Diagnostic Testing Market Trends And Strategies

    4. Rubella Diagnostic Testing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Rubella Diagnostic Testing Market Size and Growth

    5.1. Global Rubella Diagnostic Testing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Rubella Diagnostic Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Rubella Diagnostic Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Rubella Diagnostic Testing Market Segmentation

    6.1. Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Latex Agglutination

    Liver Function Tests

    Enzyme Immunoassay (EIA)

    Radioimmunoassay (Ria)

    Fluorescent Immunoassay (FIA)

    Other Diagnostic Techniques

    6.2. Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Neonates

    Teenagers

    Adults

    6.3. Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Hospitals And Clinics

    Cancer Diagnostic Centers

    Ambulatory Surgical Centers

    Other End Users

    7. Rubella Diagnostic Testing Market Regional And Country Analysis

    7.1. Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Rubella Diagnostic Testing Market

    8.1. Asia-Pacific Rubella Diagnostic Testing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Rubella Diagnostic Testing Market

    9.1. China Rubella Diagnostic Testing Market Overview

    9.2. China Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Rubella Diagnostic Testing Market

    10.1. India Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Rubella Diagnostic Testing Market

    11.1. Japan Rubella Diagnostic Testing Market Overview

    11.2. Japan Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Rubella Diagnostic Testing Market

    12.1. Australia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Rubella Diagnostic Testing Market

    13.1. Indonesia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Rubella Diagnostic Testing Market

    14.1. South Korea Rubella Diagnostic Testing Market Overview

    14.2. South Korea Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Rubella Diagnostic Testing Market

    15.1. Western Europe Rubella Diagnostic Testing Market Overview

    15.2. Western Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Rubella Diagnostic Testing Market

    16.1. UK Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Rubella Diagnostic Testing Market

    17.1. Germany Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Rubella Diagnostic Testing Market

    18.1. France Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Rubella Diagnostic Testing Market

    19.1. Italy Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Rubella Diagnostic Testing Market

    20.1. Spain Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Rubella Diagnostic Testing Market

    21.1. Eastern Europe Rubella Diagnostic Testing Market Overview

    21.2. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Rubella Diagnostic Testing Market

    22.1. Russia Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Rubella Diagnostic Testing Market

    23.1. North America Rubella Diagnostic Testing Market Overview

    23.2. North America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Rubella Diagnostic Testing Market

    24.1. USA Rubella Diagnostic Testing Market Overview

    24.2. USA Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Rubella Diagnostic Testing Market

    25.1. Canada Rubella Diagnostic Testing Market Overview

    25.2. Canada Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Rubella Diagnostic Testing Market

    26.1. South America Rubella Diagnostic Testing Market Overview

    26.2. South America Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Rubella Diagnostic Testing Market

    27.1. Brazil Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Rubella Diagnostic Testing Market

    28.1. Middle East Rubella Diagnostic Testing Market Overview

    28.2. Middle East Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Rubella Diagnostic Testing Market

    29.1. Africa Rubella Diagnostic Testing Market Overview

    29.2. Africa Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Rubella Diagnostic Testing Market Competitive Landscape And Company Profiles

    30.1. Rubella Diagnostic Testing Market Competitive Landscape

    30.2. Rubella Diagnostic Testing Market Company Profiles

    30.2.1. Cardinal Health Inc.

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Siemens Healthineers AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Thermo Fisher Scientific Inc.

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Abbott Laboratories

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. F. Hoffmann-La Roche Ltd

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Rubella Diagnostic Testing Market Other Major And Innovative Companies

    31.1. bioMérieux S.A.

    31.2. Bio-Rad Laboratories Inc.

    31.3. Ortho-Clinical Diagnostics Inc.

    31.4. DiaSorin S.p.A.

    31.5. Meridian Bioscience Inc.

    31.6. Fortress Diagnostics Ltd.

    31.7. Mylab Discovery Solutions Pvt. Ltd.

    31.8. MP Biomedicals LLC

    31.9. CTK Biotech Inc.

    31.10. ZEUS Scientific Inc.

    31.11. Creative Diagnostics

    31.12. Arlington Scientific Inc.

    31.13. AccuBioTech Co. Ltd.

    31.14. Intec Products Inc.

    31.15. Vitrosens Biotechnology Ltd.

    32. Global Rubella Diagnostic Testing Market Competitive Benchmarking

    33. Global Rubella Diagnostic Testing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Rubella Diagnostic Testing Market

    35. Rubella Diagnostic Testing Market Future Outlook and Potential Analysis

    35.1 Rubella Diagnostic Testing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Rubella Diagnostic Testing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Rubella Diagnostic Testing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Cardinal Health Inc. Financial Performance
  • Table 75: Siemens Healthineers AG Financial Performance
  • Table 76: Thermo Fisher Scientific Inc. Financial Performance
  • Table 77: Abbott Laboratories Financial Performance
  • Table 78: F. Hoffmann-La Roche Ltd Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Rubella Diagnostic Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Rubella Diagnostic Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Rubella Diagnostic Testing Market, Segmentation By Diagnostic Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Rubella Diagnostic Testing Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Rubella Diagnostic Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Cardinal Health Inc. Financial Performance
  • Figure 75: Siemens Healthineers AG Financial Performance
  • Figure 76: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 77: Abbott Laboratories Financial Performance
  • Figure 78: F. Hoffmann-La Roche Ltd Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the rubella diagnostic testing market?

Rubella diagnostic testing refers to the methods used to detect the presence of rubella virus or antibodies in a patient's blood to confirm if they have been infected with rubella or have immunity against it. These tests help healthcare providers diagnose rubella accurately and manage its implications, especially in vulnerable populations. For further insights on the rubella diagnostic testing market, request a sample here

How will the rubella diagnostic testing market drivers and restraints affect the rubella diagnostic testing market dynamics? What forces will shape the rubella diagnostic testing industry going forward?

The rubella diagnostic testing market major growth driver - The Rising Cases Of Viral Infections Propelling The Growth Of The Rubella Diagnostic Testing Market. For further insights on the rubella diagnostic testing market, request a sample here

What is the forecast market size or the forecast market value of the rubella diagnostic testing market?

The rubella diagnostic testing market size has grown strongly in recent years. It will grow from $1.22 billion in 2023 to $1.30 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to a rise in vaccination programs, a rising incidence of immunization-preventable outbreaks, government initiatives to combat the rubella virus, and the expansion of diagnostic testing in non-traditional settings. The rubella diagnostic testing market size is expected to see strong growth in the next few years. It will grow to $1.68 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing healthcare expenditure, growing focus on preventive healthcare, rising awareness of vaccine-preventable diseases, growing public health campaigns, and expansion of telemedicine and remote diagnostics. Major trends in the forecast period include advancements in diagnostic technologies, technological integration in healthcare systems, development of point-of-care testing solutions, development of new diagnostic methods, and advancements in molecular diagnostics. For further insights on the rubella diagnostic testing market, request a sample here

How is the rubella diagnostic testing market segmented?

The rubella diagnostic testing market is segmented
1) By Diagnostic Technique: Latex Agglutination, Liver Function Tests, Enzyme Immunoassay (EIA), Radioimmunoassay (Ria), Fluorescent Immunoassay (FIA), Other Diagnostic Techniques
2) By Age Group: Neonates, Teenagers, Adults
3) By End User: Hospitals And Clinics, Cancer Diagnostic Centers, Ambulatory Surgical Centers, Other End UsersFor further insights on the rubella diagnostic testing market,
request a sample here

Which region has the largest share of the rubella diagnostic testing market? What are the other regions covered in the report?

North America was the largest region in the rubella diagnostic testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the rubella diagnostic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the rubella diagnostic testing market, request a sample here.

Who are the major players in the rubella diagnostic testing market?

Major companies operating in the rubella diagnostic testing market are Cardinal Health Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Abbott Laboratories, F. Hoffmann-La Roche Ltd., bioMérieux S.A., Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., DiaSorin S.p.A., Meridian Bioscience Inc., Fortress Diagnostics Ltd., Mylab Discovery Solutions Pvt. Ltd., MP Biomedicals LLC, CTK Biotech Inc., ZEUS Scientific Inc., Creative Diagnostics, Arlington Scientific Inc., AccuBioTech Co. Ltd., Intec Products Inc., Vitrosens Biotechnology Ltd., Sprint Diagnostics Pvt. Ltd., InDevR Inc., Atlas Medical GmbH For further insights on the rubella diagnostic testing market, request a sample here.

What are the key trends in the rubella diagnostic testing market?

Major trend in the rubella diagnostic testing market - Innovative Solutions In Rubella Diagnostics And Vaccination. For further insights on the rubella diagnostic testing market, request a sample here.

What are the major opportunities in the rubella diagnostic testing market? What are the strategies for the rubella diagnostic testing market?

For detailed insights on the major opportunities and strategies in the rubella diagnostic testing market, request a sample here.

How does the rubella diagnostic testing market relate to the overall economy and other similar markets?

For detailed insights on rubella diagnostic testing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the rubella diagnostic testing industry?

For detailed insights on the mergers and acquisitions in the rubella diagnostic testing industry, request a sample here.

What are the key dynamics influencing the rubella diagnostic testing market growth? SWOT analysis of the rubella diagnostic testing market.

For detailed insights on the key dynamics influencing the rubella diagnostic testing market growth and SWOT analysis of the rubella diagnostic testing industry, request a sample here.